Neoadjuvant Immunotherapy in Melanoma: Where We Are and Where We Aren't

被引：0
|
作者：
Patel, Sapna P. [1 ,2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr Houston, Dept Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Uveal Melanoma Program, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Melanoma Fellowship Program, Houston, TX 77030 USA
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 10期
关键词：
ADJUVANT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：36
相关论文
共 50 条
  • [1] Neoadjuvant Therapy in Melanoma: Where Are We Now?
    Saad, Mariam
    Tarhini, Ahmad A.
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (04) : 325 - 339
  • [2] Neoadjuvant Therapy in Melanoma: Where Are We Now?
    Mariam Saad
    Ahmad A. Tarhini
    [J]. Current Oncology Reports, 2023, 25 : 325 - 339
  • [3] Melanoma: Where we are and where we go
    Mohammadpour, Ali
    Derakhshan, Maryam
    Darabi, Hassan
    Hedayat, Pegah
    Momeni, Mohammad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3307 - 3320
  • [4] Prostate cancer immunotherapy: where are we and where are we going?
    De Velasco, Marco A.
    Uemura, Hirotsugu
    [J]. CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 15 - 24
  • [5] Neoadjuvant treatment of rectal cancer: Where we are and where we are going
    Del Portillo, Elisabet Gonzalez
    Counago, Felipe
    Lopez-Campos, Fernando
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (07):
  • [6] Immunotherapy of multiple sclerosis: Where are we? Where should we go?
    Roland Martin
    Claus-Steffen Stürzebecher
    Henry F. McFarland
    [J]. Nature Immunology, 2001, 2 : 785 - 788
  • [7] Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?
    Martin, R
    Stürzebecher, CS
    McFarland, HF
    [J]. NATURE IMMUNOLOGY, 2001, 2 (09) : 785 - 788
  • [8] Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?
    Zayac, Adam
    Almhanna, Khaldoun
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [9] Biomarkers and immunotherapy: where are we?
    Langouo Fontsa, Mireille
    Padonou, Francine
    Willard-Gallo, Karen
    [J]. CURRENT OPINION IN ONCOLOGY, 2022, 34 (05) : 579 - 586
  • [10] Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
    Coppola, Alessandro
    Farolfi, Tommaso
    La Vaccara, Vincenzo
    Iannone, Immacolata
    Giovinazzo, Francesco
    Panettieri, Elena
    Tarallo, Mariarita
    Cammarata, Roberto
    Coppola, Roberto
    Caputo, Damiano
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
12345